Prognostic significance of mmp-1, mmp-3, and mthfr genetic polymorphism for evaluation of uterine leiomyoma and adenomyosis progression

Cover Page


Cite item

Full Text

Abstract

Carriage of hyperactive alleles of matrix metalloproteinase-1 (MMP-1) gene is associated with enhanced growth of various neoplasias in humans. When studying the frequency of promoter variants of MMP -1 and -3 genes in 170 patients with uterine leiomyoma, significant associations were revealed between low incidence of MMP-1 1G/1G genotype, high growth rates of leiomyoma, multifocal growth and more common adenomyosis development, thus presuming a protective role of MMP-1/1G homozygosity in the development of symptomatic myoma and adenomyosis and growth-promoting effect of the 2G allele. Hence, the promoter genotype of MMP-1 may be considered as possible genetic marker to predict clinical course of the uterine leiomyoma.

About the authors

Е. В. Morozova

State Medical University named after acad. I.P. Pavlova; Medical Academy of Postgraduate Education

Author for correspondence.
Email: info@eco-vector.com

Scientific and Methodological Center for Molecular Medicine of the Ministry of Health of the Russian Federation

Russian Federation, Saint Petersburg; Saint Petersburg

А. B. Chukhlovin

State Medical University named after acad. I.P. Pavlova; Medical Academy of Postgraduate Education

Email: info@eco-vector.com

Scientific and Methodological Center for Molecular Medicine of the Ministry of Health of the Russian Federation

Russian Federation, Saint Petersburg; Saint Petersburg

N. V. Kulagina

State Medical University named after acad. I.P. Pavlova; Medical Academy of Postgraduate Education

Email: info@eco-vector.com

Scientific and Methodological Center for Molecular Medicine of the Ministry of Health of the Russian Federation

Russian Federation, Saint Petersburg; Saint Petersburg

А. А. Totolian

State Medical University named after acad. I.P. Pavlova; Medical Academy of Postgraduate Education

Email: info@eco-vector.com

Scientific and Methodological Center for Molecular Medicine of the Ministry of Health of the Russian Federation

Russian Federation, Saint Petersburg; Saint Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Schedule

Download (5KB)

Copyright (c) 2005 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).